U.S. Markets closed

Immunic, Inc. (IMUX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.83-0.34 (-3.71%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.03
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 328.21
52 Week Low 38.64
50-Day Moving Average 311.66
200-Day Moving Average 314.63

Share Statistics

Avg Vol (3 month) 3214.59k
Avg Vol (10 day) 3225.76k
Shares Outstanding 521.75M
Implied Shares Outstanding 6N/A
Float 14.09M
% Held by Insiders 129.67%
% Held by Institutions 146.06%
Shares Short (Apr 14, 2021) 41.45M
Short Ratio (Apr 14, 2021) 49.05
Short % of Float (Apr 14, 2021) 47.68%
Short % of Shares Outstanding (Apr 14, 2021) 46.68%
Shares Short (prior month Mar 14, 2021) 4931.78k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 14, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Apr 14, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.18%
Return on Equity (ttm)-40.54%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -48.93M
Net Income Avi to Common (ttm)-44.02M
Diluted EPS (ttm)-2.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)127.45M
Total Cash Per Share (mrq)6.02
Total Debt (mrq)973k
Total Debt/Equity (mrq)0.61
Current Ratio (mrq)15.93
Book Value Per Share (mrq)7.50

Cash Flow Statement

Operating Cash Flow (ttm)-46.12M
Levered Free Cash Flow (ttm)-30.37M